Unknown

Dataset Information

Efficacy and safety of oncolytic viruses in advanced or metastatic cancer: a network meta-analysis.


ABSTRACT:

Background

Oncolytic viruses (OVs) have shown prospects in advanced and metastatic cancer, and many clinical trials have been carried out. To compare OV therapies comprehensively and provide a categorized profile and ranking of efficacy and safety, a network meta-analysis was conducted.

Methods

A total of 5948 studies were screened and 13 randomized controlled trials with 1939 patients, of whom 1106 patients received OV therapies, comparing four OVs (NTX-010, pexastimogene devacirepvec (Pexa-Vec), talimogene laherparepvec (T-VEC), and pelareorep) were included in a Bayesian network meta-analysis. Eligible studies reported at least one of the following clinical outcome measures: objective response rate (ORR) and grade ≥ 3 adverse events.

Results

Compared to systemic tr

SUBMITTER: Xie R 

PROVIDER: S-EPMC8325792 | biostudies-literature | 2021 Jul

REPOSITORIES: biostudies-literature